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Abstract  
PtpA, a low-molecular weight tyrosine phosphatase, is a secreted protein of Mycobacterium tuberculosis (Mtb). Many 
secretory proteins of Mtb are known to be the prominent targets of host immune response. It plays an important role in host-
pathogen interaction and it interferes with the passing of the protein from one endosomal vesicle to the next endosomal 
vesicle in the infected macrophage. It inhibits host phagolysosomal fusion in the infected macrophages and thus allows the 
bacteria to survive within macrophages. Analysis of primary and secondary structure of the protein was done by ProtParam 
and GOR IV respectively. Since the number of negatively charged residues are higher than the positively charged residues, 
PtpA is an acidic protein. Immunity against Mtb is T-cell mediated Thus an important criterion in seeking protective antigens 
should be that they induce T-cell- mediated immunity. The characterization of PtpA inducing CD4+ T-cell responses could 
critically contribute to the development of subunit vaccines for Mtb.  Here we performed computational analysis by using 
Proped, T-cell epitope prediction program. In-silico antigenicity prediction of PtpA was done using VaxiJen. Owing to the  
resistance of this protein to the natural immune response, in-silico antigenicity and T-cell epitope prediction will be helpful to 
design better subunit vaccines to develop effective acquired immune response to Mtb. 
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INTRODUCTION 
 
     Tuberculosis is one of the most prevalent infection of human 
beings. The World Health Organisation has estimated that one third 
of the total world population is latently infected with Mtb and 5-10% 
of the infected individuals will develop active TB during their life time 
[1].  
     Mtb is an intracellular pathogen infecting primarily 
mononuclear phagocytes. The bacterium has developed intricate 
strategies to evade killing mechanisms of phagocytes.  Mtb can 
also infect nonphagocytic cells in the alveolar space including M cells, 
alveolar endothelial, and type 1 and type 2 epithelial cells [2,3].  
Dendritic cells play a very important role in the early stages of 
infection since they are much better antigen presenters than are 
macrophages [4] and presumably play a key role in activating T-cells 
with specific Mtb antigens [5,6]. While the majority of bacterial 
phagosomes undergo a process of acidification and maturation, Mtb 
inhibits this process [7, 8]. Since most macrophage killing of bacteria 
occurs in the phagolysosome  [9], intracellular pathogens have 
evolved many ways to avoid this hostile vacuolar microenvironment.    
It is known that infected macrophages in the lung, through their 
production of chemokines, attract inactivated monocytes, 
lymphocytes, and neutrophils [10], none of which kill the bacteria 
very efficiently [9].  
     Proteins released by  Mtb  to the extracellular environment  
have been the focus of much of the research directed at identifying 
antigens that induce protective immunity or those that elicit immune 
responses of diagnostic value [11]. Secreted proteins of Mtb have 
been the focus of extensive research on the development of subunit 
vaccines because these proteins are considered as the important 
targets of recognition by the immune system [12,13].  The 
mycobacterial cell envelope has been a prime target for the 
identification and characterization of surface proteins with potential 
application in drug and vaccine development.  
     The secreted Mtb protein tyrosine phosphatase (PtpA) binds 
to subunit H of the macrophage vacuolar-H+-ATPase machinery, a 
multisubunit protein complex in the phagosome membrane that 
drives luminal acidification. Macrophages’ engulfment of foreign 
bodies results in the formation of phagosome, which matures in a 
process that remodels its membrane and luminal contents through 
interaction and fusion with the endosomal network [14,15]. These 
membrane fusions allow the phagosome to acquire antimicrobial 
properties, including a profoundly acidic lumen, the hallmark of the 
macrophage maturation process [16]. More than a decade ago, 
Sturgill-Koszycki et al. showed that the macrophages fail to acidify 
phagosomes containing mycobacteria  because these phagosomes 
do not accumulate the V-ATPase responsible for phagosomal 
acidification [17]. This finding suggested inhibition of the fusion 
between membrane vesicles harboring the V-ATPase complex and 
the mycobacterial phagosome  [17]. 
     The exact mechanism by which PtpA is secreted across the 
phagosomal membrane remains unclear. However, using electron 
microscopy, neutralizing antibodies, and Western blot analysis, it has 
been shown that PtpA is present in the host cytosol milieu [18]. 
There is evidence suggesting that bacterial proteins having 
molecular size less than 70 kDa can cross the phagosomal 
membrane. It has also been shown that Mtb PtpA (MPtpA) 
dephosphorylates the host macrophage protein VPS33B, a key 
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regulator of membrane fusion, leading to inhibition of phagosome–
lysosome fusion [18]. The secreted phosphatases MptpA and MptpB 
are key virulence factors that play important 
roles in survival of Mtb during macrophage infection. These enzymes 
are therefore attractive alternative targets for chemotherapy. The 
analysis of Mtb genome indicated the presence of genes coding for 
protein tyrosine phosphatases MPtpA and MPtpB. 
     The physicochemical and the structural properties of the 
proteins are well understood with the use of computational tools. The 
statistics about a protein sequence such as number of amino acids, 
sequence length, and the physico-chemical properties of a protein 
such as molecular weight, atomic composition, extinction coefficient, 
GRAVY, aliphatic  index, instability index,  etc. can be computed 
by computational tools for the prediction and characterization of 
protein structure. The amino acid sequence provides most of the 
information required for determining and characterizing the 
molecule’s function and physical and chemical properties. 
     Mtb survives phagocytosis and replicates within macrophages. 
The secretory and cell surface proteins of Mtb which stimulates 
specific host immune response in different cell types like T-cells, B-
cells and macrophages  control the pathogenesis of the disease.  
Therefore, the identification of T-cells epitopes from proteins may 
serve to define candidate antigens with vaccine potential.  
Following infection with Mtb, both healthy subjects and patients with 
active tuberculosis develop T-cell responses against mycobacterial 
antigens.  The identification of antigens capable of eliciting CD4+ T-
cell responses and the characterization of immunodominant T-cell 
epitopes are of primary importance for the development of subunit 
vaccines for tuberculosis. The role of CD8+ T-cells in immunity to Mtb 
is less defined [19].  
     The human leukocyte antigen (HLA) system is the major 
histocompatibility complex in humans. The primary function of the 
HLA system is to regulate the immune response [20].   HLA 
studies have revealed that the allele DRB1*15 is associated with 
tuberculosis in Indians [21]. 
 
MATERIALS AND METHODS 
Primary sequence analysis            
 
     The sequence of Mtb PtpA of accession number P65716   
was retrieved from UniProt (http://www.uniprot.org/), a protein 
database, in FASTA format. The primary structure, the basic 
physico-chemical properties, of PtpA was analysed using ProtParam 
(http://web.expasy.org/protparam/ (Gasteiger E ). ProtParam  is  
available through the ExPASy server. 
 
Identification of domains 
 
     PtpA sequence was analysed using SMART (Simple Modular 
Architecture Research Tool)  and Pfam. SMART is an online 
resource (http://smart.embl.de/) for the identification and annotation 
of protein domains and analysis of protein domain architecture.  
Pfam is a widely used database of protein families and domains. 
Pfam is available via (http://pfam.sanger.ac.uk/) and is used to 
organise sequences, to find the origin and evolution of proteins and 
for identifying interesting new targets for the structure determination. 
 
Prediction of function 
 
     The biological function of PtpA was studied using ESG 
(http://kiharalab.org/web/esg.php), a sequence similarity based 
protein function prediction server. 
 
Secondary structure prediction 
 
     GOR IV (http://npsapbil.ibcp.fr/cgibin/npsam) was used to 
predict the secondary structure of PtpA. The present version, GOR 
IV uses all possible pair frequencies within a window of 17 amino 
acid residues.  
 
Antigenicity prediction 
 
     The server VaxiJen (http://www.jenner.ac.uk/VaxiJen) was 
used to analyse the antigenicity of the query protein. VaxiJen was 
developed to allow antigen classification based on the 
physicochemical properties of proteins. Protein sequences can be 
submitted as single protein or as a multiple sequence file in fasta 
format. 
 
T-cell epitope prediction 
 
     Prediction of human HLA-DR-restricted determinants within 
this antigen was performed  using a virtual matrix-based prediction 
program (ProPred).  The ProPred analysis [22] of this protein was 
performed using the server (http:www. imtech. res.in/ raghava/ 
ProPed/).  
 
RESULTS AND DISCUSSION               
 
     The low-molecular-weight protein tyrosine phosphatase  
belongs to a distinctive class of phosphotyrosine phosphatases 
(PTP).   PTPs have long been considered to be confined to 
eukaryotes and only recently the genes encoding PTPs been found 
in bacteria. A low molecular weight PTP, YwlE, was identified from 
Bacillus subtilis. YwlE shares a low sequence identity (31%) with 
LMW PTP of Mtb  [23].  MptpA shows 37% sequence identity and 
high structural similarity to the human LMW PTP.  
 
Primary sequence analysis 
 
     The sequence of MPtpA, as given below,  contains 163 AA 
with molecular weight of 17,892 Da. 
>sp|P65716|PTPA_MYCTU Probable low molecular weight protein-
tyrosine-phosphatase OS=Mtb GN=ptpA PE=1 SV=1 
 
MSDPLHVTFVCTGNICRSPMAEKMFAQQLRHRGLGDAVRVTSAG
TGNWHVSCADERAAGVLRAHGYPTDHRAAQVGTEHLAADLLVAL
DRNHARLLRQLGVEAARVRMLRSFDPRSGTHALDVEDPYYGDHS
DFEEVFAVIESALPGLHDWVDERLARNGPS 
 
     The parameters shown by ProtParam in Table 1 reveal the 
physicochemical properties of the protein.  Some amino acids like 
alanine, arginine, aspartic acid, glycine, leucine are present in high 
percentage. Lysine is present in lowest percentage and the number 
of negatively charged residues are slightly higher than positively 
charged residues. Earlier studies showed that the calculated 
molecular masses of two putative tyrosine phosphatases, designated  
as MPtpA and MPtpB ,in Mtb were 17.5 and 30 kDa  respectively. 
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Table 1. Physicochemical properties of PtpA shown by ProtParam 
No. of amino acids 163 
Molecular weight                                               17892 Da
Total number of negatively charged residues (Asp + Glu) 22 
Total number of positively charged residues (Arg + Lys)                     17 
Total no. of atoms                                               2470 
Theoretical pI                                       6.03 
Estimated half-life (mammalian reticulocytes, in vitro).                                        30 hours
Instability index (unstable)                                            42.47 
Aliphatic index 80.25 
Grand average of hydropathicity (GRAVY)                                                         -0.330 
 
Identification of domains 
 
     SMART and PFAM identifies the specific region that encodes 
the domain as shown in Table 2.1 and 2.2 respectively. SMART 
revealed that the domain LMWPc is present between amino acids 5 
and 152. Pfam classified the domain in PfamA family group with id 
PF01451. 
 
Table 2.1. Region identified by SMART that encodes the domain 
 
Name Begin End E-value 
LMWPc 5 152 3.80e-62 
 
Table 2.2. Region identified by PFAM that encodes the domain 
 
Source Domain Start End 
PfamA LMWPc 7 150 
 
     In human, there are 38 known Protein Tyrosine Phosphatases, 
which are subdivided into receptor and non-receptor. The non-
receptor phosphatases contain a single catalytic Protein Tyrosine 
Phosphatase domain.The receptor tyrosine phosphatases are 
localized to the plasma membrane and have one or two Protein 
Tyrosine Phosphatase domains and a characteristic transmembrane 
domain. Low molecular weight phosphatases  lack regulatory 
domains, unlike other tyrosine phosphatases that contain both 
catalytic and regulatory domains [24]. 
 
Prediction of function 
 
     ESG reveal the molecular function, biological function and the 
percentage distribution of the Protein in different cellular components 
as shown in Table 3.1,3.2 and 3.3 respectively.  It predicted that 99 
percent molecular function is on both phosphatase and hydrolase 
activity. The main biological function of the protein is amino acid 
dephosphorylation and it is abundantly present in the cytoplasm than 
other cellular components. 
 
Table 3.1. Molecular function terms revealed by ESG 
 
Sl No. Probability Term Description 
1 99% GO:0004721 Phosphoprotein phosphatase activity 
2 99% GO:0004725 Protein tyrosine phosphatase activity 
3 99% GO:0016787 Hydrolase activity 
4 83% GO:0003993 Acid phosphatase activity 
5 82% GO:0004726 
Non-membrane spanning protein tyrosine 
phosphatase activity 
6 10% GO:0042802 Identical protein binding 
7 9% GO:0016791 Phosphoric monoester hydrolase activity 
 
Table 3.2. Biological Process Terms revealed by ESG 
 
Sl No. Probability Term Description 
1 99% GO:0006470 
Protein amino acid 
dephosphorylation 
2 9% GO:0007165 Signal transduction 
3 9% GO:0051726 Regulation of cell cycle 
 
Table 3.3. Cellular component terms revealed by ESG 
 
Sl No. Probability Term Description 
1 83% GO:0005737 Cytoplasm 
2 10% GO:0005625 Soluble fraction 
3 9% GO:0005634 Nucleus 
4 9% GO:0005829 Cytosol 
5 83% GO:0005737 Cytoplasm 
 
Secondary structure prediction 
 
     The secondary structure prediction defined each residue into 
either alpha helix, beta sheet or random coil secondary structures.  
GOR IV analysis revealed that alpha helix is more than beta strand 
and random coil, as shown in Table 4.   
 
Table 4. GOR IV analysis results 
 
Secondary structure No. of residues Percentage 
Alpha helix   81 49.69% 
Beta sheet 18 11.04% 
Random coil                   64 39.2% 
 
Antigenicity prediction 
 
     VaxiJen classified PtpA as protective antigen because it has a 
value of 0.5014 which is above the normal threshold value of 0.5. 
 
T cell epitope prediction  
 
Table 5. The predicted epitopes using the ProPred 
Predicted HTL epitopes sequences 
LVALDRNHA 
VRM 
LRSFDPRSG 
 
     ProPred, as shown in Table 5, predicted  three T cell epitopes  
with threshold setting as three and  number of alleles as one.   
Mtb  contain around four thousand proteins. ProPred could identify 
three T-cell epitopes from PtpA that can induce immune response. 
The predicted epitopes may be used for safe subunit vaccine 
development against tuberculosis. Therefore, there is a clear need 
for programs which can effectively reduce the number of candidates 
inducing an immune response. These results demonstrate that the 
ProPred analysis can facilitate the selection of promiscuous peptides 
recognized by Th1 cells, and thus it can be useful in the identification 
of peptide-based vaccine candidates against TB. T-cell epitope 
prediction on some of the secretory proteins has been done earlier 
by [25].  
 
CONCLUSION    
 
     The studies on the secreted proteins in Mtb help in the 
immunological characterization of these proteins to define their 
potential for immunological diagnosis of tuberculosis or vaccine 
design. Identifying molecules present on the surface of the organism 
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that can act as ligand and help in the entry of the pathogen into the 
host cell. Immune response developed against these proteins can 
stop receptor-ligand interactions and prevent invasion into host cells.  
Prediction of antigenic epitopes on the protein surfaces is important 
for vaccine design and only a few structure-based epitope prediction 
algorithms are available and they have not yet shown satisfying 
performance. 
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